DOP2009000117A - TETRAHYDROCICLOPENTA [B] INDOL COMPOUNDS AS ANDROGEN RECEIVER MODULATORS - Google Patents

TETRAHYDROCICLOPENTA [B] INDOL COMPOUNDS AS ANDROGEN RECEIVER MODULATORS

Info

Publication number
DOP2009000117A
DOP2009000117A DO2009000117A DO2009000117A DOP2009000117A DO P2009000117 A DOP2009000117 A DO P2009000117A DO 2009000117 A DO2009000117 A DO 2009000117A DO 2009000117 A DO2009000117 A DO 2009000117A DO P2009000117 A DOP2009000117 A DO P2009000117A
Authority
DO
Dominican Republic
Prior art keywords
tetrahydrociclopenta
compound
formula
receiver modulators
indol compounds
Prior art date
Application number
DO2009000117A
Other languages
Spanish (es)
Inventor
Konstantinos Gavardinas
Jonathan Edward
Prabhakar Kondaji Jadhav
Donald Paul Matthews
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to DO2009000117A priority Critical patent/DOP2009000117A/en
Publication of DOP2009000117A publication Critical patent/DOP2009000117A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona un compuesto de la fórmula: o una sal farmacéuticamente aceptable del mismo; composiciones farmacéuticas que comprenden un compuesto de la Fórmula (1) en combinación con un portador, disluyente, o excipiente adecuado; y m?0todos para tratar trastornos fisiológicos, particulamente reducir la masa en los huesos, osteoporosis, osteopenia, o reducción de masa o fuerza muscular, que comprende administrar un compuesto de la Fórmula (I), o una sal farmacéuticamente aceptable del mismo.The present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof; Pharmaceutical compositions comprising a compound of Formula (1) in combination with a suitable carrier, detergent, or excipient; and methods for treating physiological disorders, particularly reducing bone mass, osteoporosis, osteopenia, or reduction of muscle mass or strength, which comprises administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

DO2009000117A 2009-05-19 2009-05-19 TETRAHYDROCICLOPENTA [B] INDOL COMPOUNDS AS ANDROGEN RECEIVER MODULATORS DOP2009000117A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2009000117A DOP2009000117A (en) 2009-05-19 2009-05-19 TETRAHYDROCICLOPENTA [B] INDOL COMPOUNDS AS ANDROGEN RECEIVER MODULATORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2009000117A DOP2009000117A (en) 2009-05-19 2009-05-19 TETRAHYDROCICLOPENTA [B] INDOL COMPOUNDS AS ANDROGEN RECEIVER MODULATORS

Publications (1)

Publication Number Publication Date
DOP2009000117A true DOP2009000117A (en) 2009-05-31

Family

ID=44261577

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2009000117A DOP2009000117A (en) 2009-05-19 2009-05-19 TETRAHYDROCICLOPENTA [B] INDOL COMPOUNDS AS ANDROGEN RECEIVER MODULATORS

Country Status (1)

Country Link
DO (1) DOP2009000117A (en)

Similar Documents

Publication Publication Date Title
ECSP099350A (en) TETRAHYDROCICLOPENTA COMPOUNDS [b] INDOL AS MODULATORS
EA201071317A1 (en) TETRAHYDROCYCLOPENT [b] INDOAL MODULATORS ANDROGEN RECEPTORS
PL1891038T3 (en) Substituted n-arylpyrrolidines as selective androgen receptor modulators
ATE457979T1 (en) TETRAHYDROCARBAZOLE DERIVATIVES USABLE AS ANDROGEN RECEPTOR MODULATORS
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
EA201491607A1 (en) MODULATORS OF TALL-LIKE RECEPTORS
MX2022009942A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same.
MX2009002666A (en) N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same.
MX2009013989A (en) Combination therapy for depression.
MY149731A (en) Compounds
TN2011000437A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
MY156288A (en) Pharmaceutical formulations containing dopamine receptor ligands.
MX2010013682A (en) Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders.
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
MX2012007217A (en) (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses.
MX2011008857A (en) Oxyindole derivatives with motilin receptor agonistic activity.
DOP2009000117A (en) TETRAHYDROCICLOPENTA [B] INDOL COMPOUNDS AS ANDROGEN RECEIVER MODULATORS
MX2010007607A (en) (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid.
TN2011000018A1 (en) Pharmaceutical formulations containing dopamine receptor ligands
TR201901677T4 (en) Oral formulations of cytidine analogs and methods of their use.
UA106219C2 (en) Modulators of toll-like receptors